T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET
Company Participants
Malcolm MacLeod - IR
Philip Taylor - Gilmartin Group
John Sperzel - Chairman and CEO
John Sprague - CFO
Brett Giffin - Chief Commercial Officer
Conference Call Participants
Benjamin Haynor - Alliance Global Partners
Stephen Brozak - WBB
Operator
Good day, ladies and gentlemen, and welcome to the T2 Biosystems First Quarter 2022 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation.
It is now my pleasure to turn the floor over to your host, Malcolm MacLeod. Sir, the floor is yours.
Malcolm MacLeod
Thank you, operator. I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. These include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products.
Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these statements, including the risks and uncertainties described in T2 Biosystems' annual report on Form 10-K filed with the SEC on March 23, 2022, and other filings the company makes with the SEC from time-to-time. The company undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
With that, I would like to turn the call over to Chairman and CEO, John Sperzel. John?
John Sperzel
Thank you all for joining our first quarter 2022 earnings conference call. Today, I will review the company's performance in the first quarter and provide details on the progress we're making on our 3 corporate priorities. I will then turn the call over to our Chief Financial Officer, John Sprague, who will review our first quarter financial results before I make some closing remarks and we open the call for questions and answers.
First, I would like to address today's announcement related to our NASDAQ listing. Today, we received a letter from the NASDAQ stock market, informing the company that its shares of common stock have failed to comply with the $1 minimum bid price required for continued listing on the NASDAQ global market under NASDAQ Listing Rule 5450(a)(1). And as a result, the company's shares are subject to delisting.